Damora Therapeutics, Inc. (DMRA)
24.58
-0.17
(-0.69%)
USD |
NASDAQ |
Sep 16, 16:00
24.58
0.00 (0.00%)
After-Hours: 18:03
Damora Therapeutics Market Cap : 1.518B for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 1.528B |
| September 14, 2026 | 1.753B |
| September 11, 2026 | 1.735B |
| September 10, 2026 | 1.657B |
| September 09, 2026 | 1.622B |
| September 08, 2026 | 1.801B |
| September 04, 2026 | 1.856B |
| September 03, 2026 | 1.729B |
| September 02, 2026 | 1.740B |
| September 01, 2026 | 1.738B |
| August 31, 2026 | 1.740B |
| August 28, 2026 | 1.791B |
| August 27, 2026 | 1.890B |
| August 26, 2026 | 1.877B |
| August 25, 2026 | 1.891B |
| August 24, 2026 | 1.872B |
| August 21, 2026 | 1.903B |
| August 20, 2026 | 1.872B |
| August 19, 2026 | 2.003B |
| August 18, 2026 | 1.964B |
| August 17, 2026 | 1.920B |
| August 14, 2026 | 1.917B |
| August 13, 2026 | 1.898B |
| August 12, 2026 | 1.914B |
| August 11, 2026 | 1.875B |
| Date | Value |
|---|---|
| August 10, 2026 | 1.824B |
| August 07, 2026 | 1.848B |
| August 06, 2026 | 1.845B |
| August 05, 2026 | 1.860B |
| August 04, 2026 | 1.811B |
| August 03, 2026 | 1.723B |
| July 31, 2026 | 1.749B |
| July 30, 2026 | 1.762B |
| July 29, 2026 | 1.709B |
| July 28, 2026 | 1.775B |
| July 27, 2026 | 1.776B |
| July 24, 2026 | 1.738B |
| July 23, 2026 | 1.760B |
| July 22, 2026 | 1.809B |
| July 21, 2026 | 1.990B |
| July 20, 2026 | 1.990B |
| July 17, 2026 | 1.899B |
| July 16, 2026 | 1.824B |
| July 15, 2026 | 1.867B |
| July 14, 2026 | 1.869B |
| July 13, 2026 | 1.689B |
| July 10, 2026 | 1.721B |
| July 09, 2026 | 1.857B |
| July 08, 2026 | 1.661B |
| July 07, 2026 | 1.810B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.737B |
| Alnylam Pharmaceuticals, Inc. | 32.03B |
| Anika Therapeutics, Inc. | 279.17M |
| Savara, Inc. | 1.056B |
| Vericel Corp. | 2.057B |
Market Cap Related Metrics
| PEG Ratio | -0.0002 |
| Price to Book Value | 3.932 |
| Price | 24.58 |
| Earnings Yield | -507.7% |
| PEGY Ratio | -0.0002 |